PhD Scientific Days 2024

Budapest, 9-10 July 2024

Pathological and Oncological Sciences III.

Investigation of Novel Therapeutic Targets in Small Cell Lung Cancer – Dual Inhibition of BCL-2 and MCL-1

Author(s)

Veronika Pozonec1,2, Zsolt Megyesfalvi1,3,4, Zsuzsanna Valko4,5, Anna Schwendenwein5, Christian Lang5, Sandor Paku6, Nandor Barany4,5,6, Bence Ferencz1,4, Erzsebet Schlegl4, Kristiina Boettiger5, Melinda Rezeli7, Gyorgy Marko-Varga7, Ferenc Renyi-Vamos1,4, Mir Alireza Hoda5, Thomas Klikovits5,8, Konrad Hoetzenecker5, Michael Grusch9, Viktoria Laszlo4,5, Balazs Dome1,4,5,10, Karin Schelch5,9
1: Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary
2: Department of Head and Neck Oncology, Multidisciplinary Head and Neck Center, National Institute of Oncology, Budapest, Hungary
3: Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria
4: National Koranyi Institute of Pulmonology, Budapest, Hungary
5: Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
6: Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
7: Department of Biomedical Engineering, Lund University, Lund, Sweden
8: Department of Thoracic Surgery, Klinik Floridsdorf, Vienna, Austria
9: Center for Cancer Research, Medical University of Vienna, Vienna, Austria
10: Department of Translational Medicine, Lund University, Sweden